Last reviewed · How we verify
NCT05586633
The Efficacy of Ultrasound-guided Ozone Injection in the Treatment of Patients With Chronic Low Back Pain
NA trial testing deep paravertebral periforaminal ozone injeciton in Low Back Pain, Posterior Compartment in 50 participants. Status unknown.
1 November 2022
Quick facts
| Lead sponsor | Gaziler Physical Medicine and Rehabilitation Education and Research Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 November 2021 |
| Primary completion | 1 November 2022 |
| Estimated completion | 1 November 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- deep paravertebral periforaminal ozone injeciton
- transforaminal steroid injeciton
Conditions studied
- Low Back Pain, Posterior Compartment — all drugs for Low Back Pain, Posterior Compartment →
Sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Who can join
Adults 20 to 70, any sex, with Low Back Pain, Posterior Compartment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Low back pain is a common disorder that every individual in the society is likely to meet throughout his/her life. Low back pain lasting longer than 12 weeks is defined as chronic low back pain and causes serious disability in the community. Conservative, pharmacological, interventional and surgical treatment options are available in its treatment. In this study, it was aimed to determine the effects of ultrasound-guided deep paravertebral periforaminal ozone injection treatment on physical examination, functional independence, quality of life and pain scores in patients with chronic low back and leg pain and to compare it with transforaminal epidural steroid injection treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of ultrasonography-guided periforaminal oxygen-ozone therapy in chronic low back pain.
Ülgen Kiratlioğlu E, Tezel K, Gürçay E. · · 2025 · cited 1× · PMID 40686713 · DOI 10.55730/1300-0144.6015
Verify or expand the search:
- PubMed search for NCT05586633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials
Trials by the same sponsor.
- NCT07207694 — WhatsApp-Based Education Program for Stroke Patients · NA · not yet recruiting
- NCT07472543 — Impact of Virtual Reality (VR) Based Exercises on Lower Limb Lymphedema Outcomes (LELO) · NA · recruiting
- NCT07507357 — Tidal Model Nursing for TBI Caregivers · NA · completed
- NCT07059468 — Osteoporosis After Stroke · completed
- NCT06917027 — Comparison of Mobile Education and Face-to-Face Intermittent Catheterization Education · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05586633 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
- Last refreshed: 19 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05586633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing